Related Experiment Video
Updated: Aug 8, 2026

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
Pentoxifylline and other protein kinase C inhibitors down-regulate HIV-LTR NF-kappa B induced gene expression
D K Biswas1, C M Ahlers, B J Dezube
1Division of Cell Growth and Regulation, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.
Background:
This investigation deals with the molecular mechanism of anti-human immunodeficiency virus type 1 (HIV-1) action of pentoxifylline (PTX) [1-(5'-oxohexyl)-3, 7-dimethylxanthine] a drug widely used for the treatment of conditions involving defective regional microcirculation.
Materials And Methods:
The inhibition by PTX of protein kinase C (PKC) or cAMP-dependent protein kinase (PKA)-mediated activation by phorbol ester (PMA) and tumor necrosis factor alpha (TNF-alpha) of HIV-1-LTR-regulated reporter gene expression was studied in human CD4+ T lymphocytes (Jurkat) and human embryo kidney cells (293-27-2). A protein kinase C is involved in activation of NF-kappa B in whole cells, identified by using inhibitors specific for PKC- or PKA-catalyzed NF-kappa B activation in whole cell and cell-free systems.
Results:
PTX inhibited PKC- or PKA-catalyzed activation of NF-kappa B in cytoplasmic extracts from unstimulated Jurkat or 293-27-2 cells, but not interaction of preactivated NF-kappa B with its motifs. Calphostin C, a specific inhibitor of PKC, inhibited NF-kappa B activation and HIV-1 LTR-driven reporter gene expression in both PMA- and TNF-alpha-treated cells. In contrast, although H88 specifically inhibited PKA activity in the cell-free extract, it did not affect NF-kappa B action in PMA- or TNF-alpha-treated cells.
Conclusions:
The mechanism of inhibitory action of PTX on virus replication and NF-kappa B-induced transactivation of HIV-1 gene expression has been elucidated as due to blocking PKC-dependent PMA- or TNF-alpha-induced activation of NF-kappa B in Jurkat and 293-27-2 cells. Other protein kinase inhibitors may be useful in down regulating transcription of HIV-1 provirus and thereby virus replication in HIV-infected patients.
Insights
Pentoxifylline (PTX) inhibits human immunodeficiency virus type 1 (HIV-1) replication by blocking protein kinase C (PKC)-dependent activation of NF-kappa B. This finding suggests other kinase inhibitors may help manage HIV-1 infection.
Area of Science:
- Molecular Biology
- Virology
- Pharmacology
Background:
- Pentoxifylline (PTX) is used to treat circulatory disorders.
- Its anti-human immunodeficiency virus type 1 (HIV-1) mechanism is under investigation.
- PTX's molecular action against HIV-1 is explored.
Purpose of the Study:
- To elucidate the molecular mechanism of pentoxifylline's anti-HIV-1 action.
- To investigate PTX's effect on HIV-1 LTR-regulated gene expression.
- To determine the role of protein kinases in PTX's antiviral activity.
Main Methods:
- Studied inhibition of PKC and PKA-mediated activation of HIV-1 LTR reporter gene expression by PTX.
- Utilized human CD4+ T lymphocytes (Jurkat) and human embryo kidney cells (293-27-2).
- Employed specific inhibitors for PKC and PKA in cell-free and whole-cell systems to analyze NF-kappa B activation.
Main Results:
- PTX inhibited PKC- or PKA-catalyzed NF-kappa B activation in cytoplasmic extracts.
- Calphostin C (PKC inhibitor) reduced NF-kappa B activation and HIV-1 LTR reporter gene expression.
- H88 (PKA inhibitor) did not affect NF-kappa B action in treated cells, indicating PKC's primary role.
Conclusions:
- PTX inhibits HIV-1 replication by blocking PKC-dependent activation of NF-kappa B.
- This mechanism involves inhibiting PMA- or TNF-alpha-induced NF-kappa B activation in Jurkat and 293-27-2 cells.
- Protein kinase inhibitors may offer a strategy to down-regulate HIV-1 provirus transcription and replication.
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Inhibition of Cdk Activity
The JAK-STAT Signaling Pathway
Inhibition of CDK Activity
Inhibitors of Viral Protein Synthesis

